Stay updated on rFVIIIFc Safety/Efficacy in Hemophilia A Clinical Trial
Sign up to get notified when there's something new on the rFVIIIFc Safety/Efficacy in Hemophilia A Clinical Trial page.

Latest updates to the rFVIIIFc Safety/Efficacy in Hemophilia A Clinical Trial page
- Check5 days agoChange DetectedThe screenshots show only minor layout updates and formatting changes with no modification to the study's core content, endpoints, or listed locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check12 days agoNo Change Detected
- Check34 days agoChange Detected- Core content update: new operating status notice and current status guidance. - Names/terms updated: Hemophilia A (capitalization) and software revision to v3.2.0. - Deprecated terms: Hemophilia a and v3.0.2 removed.SummaryDifference3%

- Check35 days agoChange DetectedUpdated terminology to standardized capitalization and bumped version from v3.0.2 to v3.1.0 to reflect a new release.SummaryDifference0.1%

- Check50 days agoChange Detected- Updated the page revision to v3.0.2 and removed the 'Back to Top' element. Core content such as pricing, stock, and names remains unchanged.SummaryDifference0.1%

- Check57 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.1%

- Check64 days agoChange DetectedThe web page has undergone significant updates, including the addition of a new facility name and location details, as well as a comprehensive list of countries and cities related to hemophilia A. Additionally, there is a new reference to a post hoc analysis of hemophilia A patients.SummaryDifference4%

Stay in the know with updates to rFVIIIFc Safety/Efficacy in Hemophilia A Clinical Trial
Enter your email address, and we'll notify you when there's something new on the rFVIIIFc Safety/Efficacy in Hemophilia A Clinical Trial page.